Skip to main content
. 2019 Sep 17;17(9):539. doi: 10.3390/md17090539
anti-fXa anti-factor Xa
aPTT activated partial thromboplastin time
βTG β-thromboglobulin
CPB cardiopulmonary bypass
ELISA enzyme-linked immunosorbent assay
GPIb glycoprotein Ib
IgG immunoglobulin G
NO nitric oxide
NPH neutral protamine Hagedorn insulin
PF4 platelet factor 4
PolyP polyphosphates
PS protamine sulfate
PT prothrombin time
TPO thrombopoietin
UFH unfractionated heparin
vWF von Willebrand factor
VEH vehicle